Procurement Summary
Country: USA
Summary: Dow Breast Cancer, Clinical Research Extension Award
Deadline: 08 Jul 2026
Posting Date: 05 May 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 140656005
Document Ref. No.: HT942526BCRPCREA
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
Summary: The Fiscal Year 2026 (Fy26) Breast Cancer Research Program (Bcrp) Clinical Research Extension Award Supports Research That Extends The Data Collection, Follow-Up, And Analysis Of Breast Cancer Clinical Studies. The Intent Of This Award Mechanism Is To Increase The Clinically Relevant Impact Of Breast Cancer Patient Participation In Clinical Studies By Addressing The Knowledge Lost Due To Early Trial Termination, Limited Patient Follow-Up, Or Suboptimal Sample And/Or Data Collection And Analysis. All Applications Must Address At Least One Of The Fy26 Bcrp Overarching Challenges Or Provide Adequate Justification For Exception.Distinctive Features:· The Research Team Must Include Two Or More Breast Cancer Consumer Advocates.· This Funding Mechanism Allows For A Single Principal Investigator (Pi), Or Two Partnering Pis Referred To As The Initiating Pi And The Partnering Pi. For The Partnering Pi Option (Ppio), Only The Initiating Pi Will Submit A Pre-Application, But Both Pis Will Need To Submit At The Full Application Stage. Be Advised, Failure To Submit All Associated (Initiating And Partnering Pi) Applications By The Deadline May Result In Administrative Withdrawal.Eligibilityeligible Applicantsmiscellaneousunrestrictedadditional Informationgrantor Contact Informationdescriptionebrap Help Desk Phone: 301-682-5507 Email: [email protected] Help Deskdocumentsfile Na...
Posted Date: 2026-05-04 00:00:00
Funding instrument type: Grant
Documents
Tender Notice